Beta Bionics (BBNX) Current Deferred Revenue (2023 - 2026)
Beta Bionics (BBNX) posted Current Deferred Revenue of $1.9 million for Q2 2026, up 10.32% sequentially from $1.7 million in Q1 2026, and up 64.86% YoY from $1.1 million in Q2 2025.
Beta Bionics (BBNX) Current Deferred Revenue (2023 - 2026) Analysis & Trends
Beta Bionics has reported Current Deferred Revenue for 4 years, with the latest figure at $1.9 million in Q2 2026.
- Quarterly Current Deferred Revenue rose 64.86% year-over-year to $1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 million (up 64.86% YoY) and the FY2025 annual result came in at $1.6 million, up 65.81% from the prior year.
- Current Deferred Revenue grew to $1.9 million in Q2 2026 per BBNX's latest filing, from $1.7 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.9 million in Q2 2026 and troughed at $87000.0 in Q4 2023.
- A 4-year average of $1.2 million and a median of $1.2 million in 2025 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2026: Current Deferred Revenue jumped 979.31% in 2024, then surged 64.86% in 2026.
- Over 4 years, Current Deferred Revenue stood at $87000.0 in 2023, then surged by 979.31% to $939000.0 in 2024, then soared by 65.81% to $1.6 million in 2025, then gained by 20.81% to $1.9 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.9 million, $1.7 million, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Beta Bionics | 865.29 Mn | 684.80 Mn | 18.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 949,000.00 |
| Dec 31, 2024 | 939,000.00 |
| Dec 31, 2023 | 87,000.00 |